The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 29, 2024

Filed:

Jan. 14, 2019
Applicant:

Gi Innovation, Inc., Seoul, KR;

Inventors:

Myoung Ho Jang, Seoul, KR;

Young Chul Sung, Seoul, KR;

Zungyoon Yang, Incheon, KR;

Assignee:

GI Innovation, Inc., Seoul, KR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/745 (2015.01); A61K 9/00 (2006.01); A61K 9/14 (2006.01); A61K 9/19 (2006.01); A61K 35/744 (2015.01); A61K 35/747 (2015.01); A61K 38/17 (2006.01); A61K 39/395 (2006.01); A61P 37/08 (2006.01); C07K 14/735 (2006.01); C07K 16/42 (2006.01);
U.S. Cl.
CPC ...
A61K 35/745 (2013.01); A61K 9/0019 (2013.01); A61K 9/0056 (2013.01); A61K 9/14 (2013.01); A61K 9/19 (2013.01); A61K 35/744 (2013.01); A61K 35/747 (2013.01); A61K 38/1774 (2013.01); A61K 39/39566 (2013.01); A61P 37/08 (2018.01); C07K 14/70535 (2013.01); C07K 16/4291 (2013.01); C07K 2317/52 (2013.01); C07K 2317/60 (2013.01); C07K 2317/92 (2013.01); C07K 2319/30 (2013.01);
Abstract

A composition containing, as active ingredients, probiotics and a polypeptide with a binding ability to IgE is disclosed. In particular, a synergistic effect of remarkably decreasing food allergy was identified at the time of combined administration of probiotics and a recombinant protein containing an extracellular domain of an alpha subunit of an IgE Fc receptor. Therefore, it is expected that the composition is highly industrially applicable due to being able to exhibit a remarkable therapeutic effect on an IgE-mediated allergic disease as compared with conventional pharmaceutical compositions.


Find Patent Forward Citations

Loading…